[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Charles River Laboratories (CRL)

Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,913,904
  • Shares Outstanding, K 48,168
  • Annual Sales, $ 4,015 M
  • Annual Income, $ -144,340 K
  • EBIT $ 576 M
  • EBITDA $ 1,144 M
  • 60-Month Beta 1.40
  • Price/Sales 2.75
  • Price/Cash Flow 10.45
  • Price/Book 3.75

Options Overview Details

View History
  • Implied Volatility 62.97% (+0.87%)
  • Historical Volatility 38.99%
  • IV Percentile 98%
  • IV Rank 78.01%
  • IV High 71.52% on 02/17/26
  • IV Low 32.66% on 09/03/25
  • Expected Move (DTE 25) 14.20 (6.26%)
  • Put/Call Vol Ratio 0.01
  • Today's Volume 141
  • Volume Avg (30-Day) 307
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 3,846
  • Open Int (30-Day) 5,010
  • Expected Range 212.39 to 240.78

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $2.72
  • Number of Estimates 6
  • High Estimate $2.79
  • Low Estimate $2.69
  • Prior Year $3.12
  • Growth Rate Est. (year over year) -12.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
202.78 +11.74%
on 06/25/26
238.85 -5.14%
on 07/23/26
+24.48 (+12.11%)
since 06/24/26
3-Month
146.20 +54.98%
on 05/19/26
238.85 -5.14%
on 07/23/26
+56.78 (+33.44%)
since 04/24/26
52-Week
144.26 +57.06%
on 09/25/25
238.85 -5.14%
on 07/23/26
+49.48 (+27.94%)
since 07/24/25

Most Recent Stories

More News
3 Profitable Stocks with Warning Signs

3 Profitable Stocks with Warning Signs

CRL : 226.58 (-1.18%)
GPRE : 16.95 (-1.45%)
NBR : 83.37 (-1.03%)
3 Healthcare Stocks We Approach with Caution

3 Healthcare Stocks We Approach with Caution

OPCH : 21.66 (+2.75%)
CRL : 226.58 (-1.18%)
QDEL : 16.05 (-3.20%)
Charles River Laboratories Earnings Preview: What to Expect

Charles River Laboratories is poised to announce its second-quarter results next month, and analysts predict a double-digit drop in the company’s bottom-line figure.

ABT : 103.06 (+2.29%)
XLV : 162.57 (+0.70%)
$SPX : 7,411.98 (+0.05%)
CRL : 226.58 (-1.18%)
Charles River Laboratories Schedules Second-Quarter 2026 Earnings Release and Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2026 financial results on Wednesday, August 5 th , before the market opens. A conference call has been...

CRL : 226.58 (-1.18%)
Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches

Collaboration aligns with Charles River’s strategic commitment to building deeper client relationships and accelerating development with alternative methods

ALA : 11.51 (-20.63%)
CRL : 226.58 (-1.18%)
3 Overrated Stocks We’re Skeptical Of

3 Overrated Stocks We’re Skeptical Of

STT : 185.40 (+0.65%)
ETSY : 80.62 (-0.36%)
CRL : 226.58 (-1.18%)
Did Charles River Laboratories International, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...

CRL : 226.58 (-1.18%)
3 Reasons to Avoid CRL and 1 Stock to Buy Instead

3 Reasons to Avoid CRL and 1 Stock to Buy Instead

CRL : 226.58 (-1.18%)
How Is Charles River Laboratories’ Stock Performance Compared to Other Health Care Stocks?

Despite underperforming its industry peers over the past year, analysts remain highly bullish on Charles River Laboratories' long-term prospects.

XLV : 162.57 (+0.70%)
CRL : 226.58 (-1.18%)
IQV : 208.05 (+0.35%)
Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise

Collaboration supports Charles River’s strategic goals to build deeper client relationships to further modernize R&D through innovative technologies

CRL : 226.58 (-1.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research...

See More

Key Turning Points

3rd Resistance Point 237.64
2nd Resistance Point 234.81
1st Resistance Point 230.69
Last Price 226.58
1st Support Level 223.75
2nd Support Level 220.92
3rd Support Level 216.80

See More

52-Week High 238.85
Last Price 226.58
Fibonacci 61.8% 202.72
Fibonacci 50% 191.55
Fibonacci 38.2% 180.39
52-Week Low 144.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.